User:AnonymousUsernam33/sandbox

This is my test edit for the second week of assignments for Endocrinology. It's nice that we are taking small steps as we (well me anyway) learn to manipulate Wikipedia.For the edits I will be making in the IGF-1 article, I will be focusing on the therapeutic agent section.

Use as a therapeutic agent
Patients with severe primary insulin-like growth factor-1 deficiency (IGFD), called Laron syndrome, may be treated with either IGF-1 alone or in combination with IGFBP-3. Mecasermin (brand name Increlex) is a synthetic analog of IGF-1 which is approved for the treatment of growth failure. IGF-1 has been manufactured recombinantly on a large scale using both yeast and E. coli.

There are more uses for IGF-1 in a therapeutic capacity. Researchers have found that IGF-1 may have a beneficial effect on atherosclerosis and cardiovascular disease. IGF-1 has also been shown to have an antidepressant effect in mouse models.

More detail to come...

I also don't like how my second citation was automatically formatted.